1. Seroconversion from HBe antigen to antiHBe in chronic hepatitis B virus infection;Realdi, G.; Alberti, A.; Rugge, M.; Bortolotti, F.; Rigoli, A.M.; Tremolada, F.;Gastroenterology,1980
2. Seroconversion from HBe antigen to antibody in chronic type B hepatitis;Hoofnagle, J.H.; Dusheiko, G.M.; Seef, L.B.; Jones, E.A.; Waggoner, J.G.; Bales, Z.B.;Ann Intemn Med,1981
3. Clinical virologic and histologic outcome following seroconversion from HBeAg to antiHBe in chronic hepatitis type B;Fattovich, G.; Rugge, M.; Brollo, L.; Pontisso, P.; Noventa, F.; Guido, M.;Hepatology,1986
4. Randomized controlled trial of recombinant human a-interferon in patients with chronic hepatitis B;Hoofnagle, J.H.; Peters, M.; Mullen, K.D.; Jones, D.B.; Rustgi, V.; Di Bisceglie, A.;Gastroenterology,1988
5. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B;Perillo, R.P.; Schiff, E.R.; Davis, G.L.; HC, Jr, Bodenheimer; Lindsay, K.; Payne, J.;N Engl 7 Med,1990